Drug
BG 75202
BG 75202: highest development phase Phase 1, developed by BeOne Medicines. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- BeOne Medicines
Trials
| Drug | Phase | Indication |
|---|---|---|
| BG-75202 NCT07222267 | Phase 1 | Breast Cancer |
Latest
No recent events.
Follow BG 75202 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.